New policy hastens approval of overseas drugs, equipment - (China Daily via NewsPoints Desk)

  • According to senior officials, access to new overseas drugs and medical equipment brought to the Chinese mainland is expected to be accelerated with the release of a new policy, China Daily reported Tuesday.

  • Data collected on the clinical use of imported drugs and medical equipment in a pilot zone in the Hainan province can be used for their registration in China, according to an implementation plan to support the development of the Boao Lecheng International Medical Tourism Pilot Zone released by four central government departments.

  • The plan outlined major tasks of the pilot zone, such as developing top level medical service providers and research institutes, and developing quality medical tourism services.

  • According to the plan, the zone will boast world class medical technologies, equipment and drugs by 2025.

  • Shen Xiaoming, governor of Hainan, said the plan is an update of a previous one released by the state council in 2013, the year when it approved the establishment of the zone, which allowed medical institutions in the zone to import and use drugs and medical equipment from overseas that are not yet approved in China.

  • "The policy will benefit many Chinese patients as they will have access to the latest drugs and most advanced medical equipment," he said, adding that "it will encourage more overseas pharmaceutical companies to export their products to China, with reduced cost and time for approval procedures."

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.